Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001234066-05-000011

Options or other derivatives

  • President & CEO acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HARRIS ROBERT B · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2005-02-03 Grant or award : show line 1 in the form Options +20,000 $5.35 $107,000 139,460 D
Loading xslF345X02/primary_doc.xml…